Dr. Antonio Calles 🫁🚭· @Tony_Calles · X·· 1 day agoScore45
Body
#ESMO26 Day+2 is about to start! ⭐️ Ready for the Rapid Orals, NSCLC metástasic #LCSM @myESMO
142 views · 2 likes · 0 reposts · 0 replies
Conference abstracts
1017Pmatched by Developmental therapeutics
Phase 1 first-in-human (FIH) results of YL211, a c-Met targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors
https://esmocongress.esmo.orgNCT06110663NCT06110663matched by - **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
- **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
https://esmocongress.esmo.orgSource: Dr. Antonio Calles 🫁🚭 · x.com